Stock listing
NASDAQ:ETNB 89bio Inc Stock
Follow 89bio Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ETNB
$14.84 USD
Close on Oct 29, 2025 · No longer trades
- Lowest – highest close
- $2.09 – $41.77 USDSince Nov 11, 2019 · lowest May 9, 2022 · highest Mar 2, 2020
Delisted NASDAQ:ETNB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ETNB
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
89bio Inc on 6ix
- Decks
- 10 decks · latest Apr 9, 2025
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2025) | Investor deck | 74 slides | Apr 9, 2025 |
| Investor Presentation (December 2023) | Investor deck | 69 slides | Dec 6, 2023 |
| Technical Presentation (March 2023) | Technical | 24 slides | Mar 22, 2023 |
| Investor Presentation (February 2023) | Investor deck | 47 slides | Feb 15, 2023 |
| Technical Presentation (June 2022) | Technical | 44 slides | Jun 28, 2022 |
| Technical Presentation (January 2022) | Technical | 21 slides | Jan 24, 2022 |
| Investor Presentation (June 2021) | Investor deck | 41 slides | Jun 10, 2021 |
| Investor Presentation (October 2020) | Investor deck | 42 slides | Oct 5, 2020 |
| Technical Presentation (September 2020) | Technical | 22 slides | Sep 14, 2020 |
| Investor Presentation (April 2020) | Investor deck | 40 slides | Apr 13, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Nov 8, 2019 |
| Martin Babler Other companies: MapLight Therapeutics, Inc. (Member of the Audit Committee · Since at least Jun 23, 2026); Alumis Inc. (President, CEO and Chairman, Director · Since at least Jun 27, 2024); Prelude Therapeutics Incorporated (Director · Since at least Jun 17, 2022); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past) | Director · Since at least Apr 13, 2024 |
| Michael Hayden Other companies: AbCellera Biologics Inc. (Lead Director · Since at least Dec 11, 2020); Ionis Pharmaceuticals, Inc. (Director · Since at least Sep 20, 2018); Aurinia Pharmaceuticals Inc (Director · Jan 1, 2021 – Jan 29, 2021 · Past); Xenon Pharmaceuticals Inc. (Director · May 25, 2016 – Jun 3, 2021 · Past) | Director · Since at least Nov 8, 2019 |
| Tomer Kariv Other companies: Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); LogicBio Therapeutics Inc (Director · Oct 18, 2018 – Dec 19, 2019 · Past); VBI Vaccines Inc. (Director · Jan 23, 2018 – Jan 31, 2019 · Past); Arno Therapeutics Inc (Director · Jan 12, 2016 – Sep 8, 2016 · Past) | Director · Nov 8, 2019 – Nov 11, 2019 · Past |
| Edward Morrow Atkinson III Other companies: Vertex Pharmaceuticals Incorporated (EVP, Chief Technical Ops. Off. · Since at least Aug 29, 2023) | Director · Since at least Feb 17, 2022 |
| Anat Naschitz | Director · Nov 8, 2019 – Apr 15, 2021 · Past |
| Ryan Martins | Chief Financial Officer · Since at least Feb 5, 2022 |
Log in to ask 6ix AI your own questions about 89bio Inc.